Clinical Trial Update: Radiation and TSR-042 (Dostarlimab) in People With Endometrial Cancer After They Receive Surgery [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the combination of radiation therapy with dostarlimab (TSR-042) in patients with endometrial cancer after surgery; currently r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer

Drugs mentioned

• Dostarlimab (dostarlimab)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Endometrial Cancer | Phase 2 | Status: RECRUITING